MADRID, Oct. 28,
2024 /PRNewswire/ -- The START Center for Cancer
Research ("START"), a global leader in early-phase cancer clinical
trials, today announced a new strategic partnership with the
Fundación Rioja Salud, a foundation dedicated to (i) the promotion
and protection of health, (ii) the training, teaching, research,
development and innovation of Health Sciences and biotechnology,
what includes drug development and medical education, and (iii) the
integration of research into clinical practice within the province
of La Rioja, Spain. This
partnership marks the establishment of an additional START early
phase unit in La Rioja, expanding START's robust network which
currently includes eight clinical trial sites worldwide and a team
of 25 Principal Investigators (PIs).
This expansion builds on START's existing presence in
Spain including two sites in
Madrid at the HM Sanchinarro
Hospital and Hospital Universitario Fundación Jiménez Díaz, as
well as a site at HM Nou Delfos Hospital in Barcelona. This announcement follows closely
on the heels of START's June announcement of a partnership with
Northwell Health to establish two new early-phase clinical trial
sites in New York.
The new START site will be co-located with San Pedro University
Hospital, which sees 1,800 new cancer patients per year.
Importantly, this location is centrally located for the northern
regions of Aragón, País Vasco, Navarra, Castilla y León, Cantabria
and Asturias. These provinces have a combined population of 8.1
million people, many of whom live over 200 miles from Madrid and Barcelona, the nearest public oncology
clinical trial sites. Juan Carlos Oliva Peréz, the CEO of Rioja
Salud Fundación added, "We are excited to join forces with START.
This partnership enables us to offer our community access to the
forefront of cancer research and treatment options that were
previously unavailable in our region."
"This partnership with Rioja Salud marks a significant milestone
in our mission to enhance access to cutting-edge cancer
treatments," expressed Nick Slack,
Chairman and CEO of START. "By expanding our network to La Rioja,
we are not only reaching more patients but also reinforcing our
commitment to pioneering cancer research and care."
Dr. Emiliano Calvo, President of
START Europe, also commented on
the expansion, "The establishment of a new early phase unit in La
Rioja is a testament to our dedication to advancing cancer
treatment for all communities in Spain and the region. Working alongside Rioja
Salud, we aim to bring innovative therapies closer to patients,
leveraging our combined expertise to make a meaningful difference
in the fight against cancer."
The new START early phase unit in La Rioja is expected to
enhance the scope of cancer clinical trials available to Spanish
patients, complementing the existing facilities in Madrid and Barcelona. This initiative underscores the
collaborative efforts of both organizations to improve patient
outcomes and advance global cancer research.
About The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START
Center for Cancer Research provides access to specialized
preclinical and early-phase clinical trials of novel anti-cancer
agents. START clinical trial sites have conducted more than a
thousand early-phase clinical trials, including for 43 therapies
that were approved by the FDA or EMA. START represents the world's
largest roster of Principal Investigators (PIs) across its eight
clinical trial sites. Committed to accelerating passage from trials
to treatments, START delivers hope to patients, families, and
physicians around the world. Learn more
at STARTresearch.com.
About Fundación Rioja Salud
Fundación Rioja Salud was established as a Foundation on
December 3, 2001, and began its
activity in June 2002. Since 2008 it
has hosted the Biomedical Research Center of La Rioja (CIBIR), a
dedicated structure for the promotion of research in Health
Sciences in La Rioja. With a staff over 200, FRS manages and
promotes the biomedical research carried out in the region and
provides advanced health resources and services.
START Media Contact:
Lauren
Panco
lauren.panco@startresearch.com
+1 609 216 4920
Fundación Rioja Salud Media Contact:
Ander Laguardia
Barrón
alaguardia@riojasalud.es
+34 941 29 84 94
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-start-center-for-cancer-research-and-fundacion-rioja-salud-announce-new-partnership-to-further-expand-access-to-early-phase-clinical-trials-in-spain-302287349.html
SOURCE The START Center for Cancer Research